47 results
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
June 5, 2023 through June 8, 2023, representatives of POINT met with representatives of Lilly while attending a healthcare conference, during which
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
of Lilly while attending a healthcare conference, during which representatives of Lilly indicated Lilly’s potential interest in the radiopharmaceuticals … served as chief counsel, corporate and securities at GE Healthcare from 2018 to 2019. Between 2015 and 2018, Mr. Anderson held various positions
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
relationships with healthcare providers and physicians and third-party payors are subject to complex and extensive healthcare laws and regulations. ◦ Healthcare … , issuance by the FDA or other regulatory authorities of safety alerts, Dear Healthcare Provider letters, press releases or other communications
424B3
pz9q7s1 d85jz
11 Jul 22
Prospectus supplement
4:32pm
POS AM
zbyuq
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
DEF 14A
6vj019sp16myyv
28 Apr 22
Definitive proxy
8:36am
424B3
7clwkixphz72sd
31 Mar 22
Prospectus supplement
11:42am
POS AM
sq35 tr2a
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
0rvpo2
5 Aug 21
Prospectus supplement
4:26pm
8-K
8vbwcsm0de63skq
21 Jun 21
Other Events
4:04pm
425
cddqbqd5
21 Jun 21
Business combination disclosure
4:02pm
424B3
3bo4od 74kfjqb9clkjc
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
addm wixopx
9 Jun 21
Other Events
4:40pm
425
EX-99.1
blhgvpcaxn 89a8
9 Jun 21
Business combination disclosure
4:38pm